Pacific Meinuoke is a CDMO that develops innovative and affordable biopharmaceuticals in the fields of oncology and infectious disease. Based in Changzhou, Jiangsu, China, the company's services include early target identification, lead identification and optimization, process development, GMP manufacturing, and preclinical and clinical testing for global registration and marketing. Pacific Meinuoke maintains a close relationship with the National Translational Science Center for Molecular Medicine, which takes a leading role in basic research for innovative biopharmaceuticals in China.